ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LY75 | Lymphocyte antigen 75 | CD markers Predicted membrane proteins
| | | | | Mixed |
MCAM | Melanoma cell adhesion molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
NT5E | 5'-nucleotidase, ecto (CD73) | CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PTGFRN | Prostaglandin F2 receptor inhibitor | CD markers Predicted membrane proteins
| | | | | Mixed |
PVR | Poliovirus receptor | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PVRL2 | Poliovirus receptor-related 2 (herpesvirus entry mediator B) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SDC1 | Syndecan 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SIRPA | Signal-regulatory protein alpha | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SLAMF7 | SLAM family member 7 | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
THBD | Thrombomodulin | Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TNFRSF14 | Tumor necrosis factor receptor superfamily, member 14 | Cancer-related genes CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |